Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Finance Watch: Investors Bet On Hope As Four Early-Stage Companies Launch US IPOs

Jun 21 2019

• By Mandy Jackson

Finance Watch

Related Content

Venture Funding Deals: Atreca Raises $125m To Advance Solid Tumor Candidate

Oct 12 2018

Early Stage Candidates Carving Out New Routes In Cystic Fibrosis

Oct 25 2018

After Tocagen Thaws IPO Freeze, Verona And Zymeworks Bring April Total To Three

Apr 29 2017

Disappointed, Yes, But Roivant's Not Roiled By Axovant's Alzheimer's Failure

Sep 27 2017

Finance Watch: Third Rock Raises $770m To Launch Up To 12 New Companies

Jun 07 2019

Roivant Splashes Cash Again To License GSK Skin Disorder Drug

Jul 13 2018

Synlogic Moves Synthetic Biotics To The Clinic For Rare Metabolic Disease

Oct 30 2017

Biohaven Pays $105m For Turbo Boost In Migraine Drug Review Race

Mar 20 2019

Glenmark’s Coup: Gilead’s Riva Now CEO Of Spin-Out Innovation Firm

Mar 07 2019

Pipeline Watch: Phase III Readouts For Ivosidenib, Abrocitinib, Spartalizumab

May 20 2019

Pipeline Watch: Phase III Starts For Linzagolix, RTB101

May 13 2019

Related Companies

Roivant Sciences Ltd.

Stoke Therapeutics, Inc.

Prevail Therapeutics Inc.

Atreca, Inc.

Akero Therapeutics, Inc.

Glenmark Pharmaceuticals Limited

Roivant Sciences Ltd.

Sio Gene Therapies, Inc.

Myovant Sciences Ltd.

Urovant Sciences, Inc.

GSK plc

Karuna Therapeutics, Inc.

BridgeBio Pharma, Inc.

Morphic Therapeutic, Inc.

Biohaven Pharmaceutical Holding Company Ltd.

Zymeworks, Inc.

Kura Oncology, Inc.

GW Pharmaceuticals plc

Synlogic, Inc.

Calithera Biosciences, Inc.

Codexis, Inc.

Scholar Rock, LLC

Genocea Biosciences, Inc.

Sevion Therapeutics, Inc.

Sesen Bio, Inc.

Additional Topics

Financing Business Strategies Innovation Growth Commercial BioPharmaceutical

More from Financing

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window